# Early Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of STR-P005

> **NCT07655453** · NA · NOT_YET_RECRUITING · sponsor: **Starna Therapeutics** · enrollment: 36 (estimated)

## Conditions studied

- Relapsed/Refractory Autoimmune Diseases

## Interventions

- **DRUG:** STR-P005

## Key facts

- **NCT ID:** NCT07655453
- **Lead sponsor:** Starna Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2027-07-30
- **Final completion:** 2028-07-30
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07655453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07655453, "Early Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of STR-P005". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07655453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*